Navigation Links
WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
Date:4/28/2008

ilding a global R&D service platform that serves pharmaceutical, biotechnology and medical device companies worldwide," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "We will continue our unremitting efforts to better serve clients and create value for our shareholders."

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com.

For more information, please contact:

Sherry Shao

Tel: +86-21-5046-4002

Email: pr@pharmatechs.com


'/>"/>
SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
2. WuXi PharmaTech Announces Second Quarter 2007 Results
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
11. WuXi PharmaTech Completes Acquisition of AppTec
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Studying hair of ancient Peruvians answers questions about stress 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3ADA releases updated position paper on nutrient supplementation 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 1Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 3Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 1Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 2The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 1The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 2The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 3The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 4